Blar i Working papers (SNF) på emneord "pharmaceuticals"

Viser treff 1-4 av 4

    • Direct to consumer advertising in pharmaceutical markets 

      Brekke, Kurt Richard; Kuhn, Michael (Working paper, Working paper, 2005-02)
      We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients differ in their susceptability ...

    • Margins and market shares : pharmacy incentives for generic substitution 

      Brekke, Kurt Richard; Holmås, Tor Helge; Straume, Odd Rune (Working paper;08/13, Working paper, 2013-02)
      We study the impact of product margins on pharmacies’ incentive to promote generics instead of brand-names. First, we construct a theoretical model where pharmacies can persuade patients with a brand-name prescription to ...

    • Pharmaceutical patents : incentives for R&D or marketing? 

      Brekke, Kurt Richard; Straume, Odd Rune (Working paper, Working paper, 2005-11)
      We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future ...

    • Regulation and pricing of pharmaceuticals : reference pricing or price cap regulation? 

      Brekke, Kurt Richard; Grasdal, Astrid Louise; Holmås, Tor Helge (Working paper, Working paper, 2006-11)
      We study the relationship between regulatory regimes and pharmaceutical firms pricing strategies using a unique policy experiment from Norway, which in 2003 introduced a reference price (RP) system called “index pricing” ...